|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02945 GENSCRIPT B-2K
Nominal 
35.560 0.000 (0.000%) | 2025/12 - Final USD(K$) | %Chg (Compare to Final) | 2024/12 USD(K$) | |
| Turnover | 959,526 | 61.404% | 594,486 |
| Cost of Sales | (406,322) | 26.046% | (322,361) |
| Gross Profit | 553,204 | 103.290% | 272,125 |
| 2025/12 - Final USD(K$) | %Chg (Compare to Final) | 2024/12 USD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | |
| Change in FV & Impairment on Others | (426,901) | 143.041% | (175,650) | |
| Profit / (Loss) on Disposal | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (320,378) | 719.968% | (39,072) | |
| Profit / (Loss) before Taxation | (470,533) | 175.493% | (170,797) | |
| Taxation | (61,871) | 1978.300% | (2,977) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | 3,029,061 | |
| Non-controlling Interests | (426) | -- | 106,590 | |
| Others | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (532,830) | -- | 2,961,877 | |
| 2025/12 - Final USD(K$) | %Chg (Compare to Final) | 2024/12 USD(K$) | |
| Net Finance Costs / (Income) | 17,294 | 115.314% | 8,032 |
| Depreciation & Amortisation | 74,039 | 20.314% | 61,538 |
| Directors' Emoluments | 3,202 | 0.250% | 3,194 |
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified |
Market Valuation Indicators
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | |
| EPS (cts) | -24.580 | -- | 139.630 |
| DPS (cts) | 0.000 | -- | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- |
| Cash flow per share ($) | 0.150 | -- | 0.036 |
| NBV per share ($) | 1.811 | -- | 2.016 |
| Remarks: | Real time quote last updated: 14/10/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | USD -129,343 |
| %Change | 407.984% |
| EPS / (LPS) | USD -0.059 |
| NBV Per Share ($) | USD 1.776 |